Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05515562 · ClinicalTrials.gov registry record · Phase 4
Effects of Intravenous (IV) Omadacycline on Gut Microbiome
A Phase 4 study of Microbial Colonization, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 4
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT05515562 is a Phase 4 study of Microbial Colonization that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 8 participants, below the 12,654-participant average among 20 other Microbial Colonization trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05515562, a Phase 4 study of Microbial Colonization, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
Given the clinical need to improve upon current antibiotic regimens for the treatment of C. difficile infection with a particular focus on the impact of therapies on gut microbiome, this study proposes to characterize the impact of Intravenous (IV) omadacycline on gut microbiome of healthy volunteers.
Conditions Studied
Interventions
- DRUG Omadacycline Injection
Study Locations (1)
North Carolina
- Wake Forest Baptist Health - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2023-03-20 |
| Est. Completion | 2023-07-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05515562
The ClinicalTrials.gov registry entry for NCT05515562 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,654-participant average among 20 other Microbial Colonization trials with a reported enrollment target (100% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Microbial Colonization appearing as the primary indexed condition, and to 1 intervention - of which Omadacycline Injection is the first listed.
NCT05515562 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT05515562 about?
NCT05515562 is a clinical study titled "Effects of Intravenous (IV) Omadacycline on Gut Microbiome". Given the clinical need to improve upon current antibiotic regimens for the treatment of C. difficile infection with a particular focus on the impact of therapies on gut microbiome, this study proposes to characterize the impact of Intravenous (IV) omadacycline on gut microbiome of healthy volunteer...
What is the current status of trial NCT05515562?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 8 participants. The study started on 2023-03-20. Estimated completion is 2023-07-11.
What conditions does trial NCT05515562 study?
This clinical trial studies the following conditions: Microbial Colonization.
What interventions are being tested in trial NCT05515562?
The interventions under investigation include: Omadacycline Injection (DRUG).
Who is sponsoring clinical trial NCT05515562?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05515562 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Microbial Colonization
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Skin Preparation for Elective Foot and Ankle Surgery
RECRUITING · Phase 4
-
NICU Antibiotics and Outcomes Trial
ACTIVE NOT RECRUITING · Phase 4
-
Changes in Microbial Status From Dentate, Edentulous and After Dental Implant Placement
RECRUITING
-
Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome
RECRUITING · Phase 1
-
Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment
RECRUITING · Phase 1
-
Effects of Mouthrinse on the Microbiome of the Oral Cavity and GI Tract
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.